| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -222,503 | -185,962 |
| Depreciation | 677 | 448 |
| Share-based compensation | 30,566 | 23,367 |
| Deferred income taxes | 43,239 | 43,239 |
| Reduction in the carrying amount of right-of-use assets | 2,083 | 1,369 |
| Loss on disposal of fixed assets | -3 | -2 |
| Accounts receivable | 0 | 0 |
| Prepaid and other assets | -9,178 | -3,883 |
| Accounts payable, accruals and other liabilities | -9,527 | -7,895 |
| Deferred revenue | -9,613 | -7,198 |
| Restructuring liability | 17,614 | 30,330 |
| Operating lease liabilities | -1,985 | -1,286 |
| Net cash used in operating activities | -140,268 | -99,703 |
| Purchases of property and equipment | 138 | 128 |
| Net cash used in investing activities | -138 | -128 |
| Proceeds from issuance of ordinary shares in at-the-market offering, net-At The Market Offering | -139 | -122 |
| Proceeds from issuance of ordinary shares upon exercise of stock options | 0 | 0 |
| Net cash provided by (used in) financing activities | -139 | -122 |
| Net decrease in cash, cash equivalents and restricted cash | -140,545 | -99,953 |
| Cash and cash equivalents at beginning of period | 472,248 | - |
| Cash and cash equivalents at end of period | 331,703 | - |
PROTHENA CORP PUBLIC LTD CO (PRTA)
PROTHENA CORP PUBLIC LTD CO (PRTA)